DR6

DR6 Informations sur la molécule

Nom anglais	Tumor necrosis factor receptor superfamily member 21	Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	0	Alias de la cible	CD358，Death receptor 6，Tumor Necrosis Factor Receptor Superfamily， Member 21，TNFR-Related Death Receptor 6，DR6，CD358 Antigen，TNF Receptor Superfamily Member 21，BM-018
Phase de R&D la plus avancée	Pending

Nom anglais	Tumor necrosis factor receptor superfamily member 21
Alias de la cible	CD358，Death receptor 6，Tumor Necrosis Factor Receptor Superfamily， Member 21，TNFR-Related Death Receptor 6，DR6，CD358 Antigen，TNF Receptor Superfamily Member 21，BM-018
Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	0
Phase de R&D la plus avancée	Pending

DR6 Liste de produits

Attribut
Protein (1)
Bibliothèque de produits
En ligne (1)
Espèces
Human (1)
Étiquette
Fc Tag (1)
Marqueur
Unconjugated (1)

Numéro de produit	Espèces	Système d'expression	Description du produit	Structure protéique	Pureté	Caractéristiques	Pré-commande/Commande
TN1-H5252	Human	HEK293	Human DR6 / TNFRSF21 Protein, Fc Tag				Ajouter au panier

Quantité totale1

DR6Contexte de la molécule

Tumor necrosis factor receptor superfamily member 21 (TNFRSF21) is also known as death receptor 6 (DR6), which is a member of the TNF-receptor superfamily. TNFRSF21 contains one death domain and four TNFR-Cys repeats. TNFRSF21 / DR6 has been shown to activate NF-κB and MAPK8/JNK, and induce cell apoptosis. Through its death domain, this receptor interacts with TRADD protein, which is known to serve as an adaptor that mediates signal transduction of TNF-receptors.